MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Stereotypy after bilateral opercular infarctions.

    H. Wang, K. Mongeon-Wahlen, F. Ali (Mankato, USA)

    Objective: To report a case of stereotypy after bilateral opercular infarctions. Background: Stereotypies are repetitive, patterned and purposeless involuntary behaviors that are usually distractible[1, 2].…
  • MDS Virtual Congress 2021

    Tremor in dystonia is associated with increased brain activity in the cerebellum and pallidum

    F. Nieuwhof, I. Toni, A. Buijink, A. van Rootselaar, C. Gallea, M. Vidailhet, B. Vande Warrenburg, R. Helmich (Nijmegen, Netherlands)

    Objective: To identify brain regions showing tremor-related activity in patients with dystonic tremor syndrome. Background: Dystonic tremor syndromes are highly burdensome and treatment is often…
  • MDS Virtual Congress 2021

    Neuronal intranuclear inclusion disease tremor-dominant subtype: a mimicker of essential tremor

    D. Yang, Z. Cen, L. Wang, X. Chen, P. Liu, H. Wang, Z. Ouyang, W. Luo (Hangzhou, China)

    Objective: This study aimed to clarify the clinical phenotype in tremor-dominant patients having the GGC repeat expansion in the NOTCH2NLC gene. Background: The GGC repeat…
  • MDS Virtual Congress 2021

    Comparison of pre – and post – clinical outcomes after COVID-19 lockdown in people with Parkinson’s in Portugal

    C. Godinho, D. Tavares, J. Dean, J. Domingos (Sintra, Portugal)

    Objective: We compare several pre- and post-clinical outcomes to assess the effects in a group of Portuguese people with PD. Background: Government-mandated restrictions due to…
  • MDS Virtual Congress 2021

    Prevalence and Clinical Characteristics of Autosomal Dominant Spinocerebellar Ataxia in a Large Canadian Cohort from Ontario

    R. Munhoz, E. Slow, S. Alshimemeri (Toronto, Canada)

    Objective: To describe the prevalence and clinical characteristics of Autosomal Dominant (AD) Spinocerebellar Ataxias (SCA) in a Canadian cohort of patients in Ontario. Background: SCAs…
  • MDS Virtual Congress 2021

    Clinical phenotype and biomarkers in sporadic degenerative ataxia: longitudinal data from the SPORTAX registry

    D. önder, C. Wilke, J. Faber, T. Schaprian, I. Giordano, M. Grobe-Einsler, L. Schöls, S. Vielhaber, J. Machts, C. Kamm, A. Dudesek, T. Klopstock, C. Stendel, D. Timmann-Braun, S. Boesch, A. Eigentler, B. van Dewarrenburg, J. van Gaalen, C. Tallaksen, I. Wedding, A. Filla, G. Silvestri, M. Masciullo, C. Ganos, J. Kang, D. Sarah, M. Synofzik, T. Klockgether (Bonn, Germany)

    Objective: Our aim was to survey the natural history of sporadic degenerative ataxia and analyze the long-term disease progression. Furthermore, we wanted to examine and…
  • MDS Virtual Congress 2021

    Choreoathetosis in the setting of HHV-6 infection in an allogeneic transplant recipient

    S. Mancone, C. Selvadurai, J. Baehring, A. Patel (New Haven, USA)

    Objective: To illustrate a novel case of adult-onset choreoathetosis in the setting of HHV-6 infection Background: Human herpesvirus-6 (HHV-6) has been associated with a spectrum…
  • MDS Virtual Congress 2021

    Homeostatic Improvement of Brain Bioenergetic Metabolism in Parkinson’s Disease: Results From A Phase 2 REPAIR-PD Clinical Trial With CNM-Au8

    R. Glanzman, J. Ren, Phd, R. Dewey, Iii, A. Rynders, K. Ho, Phd, R. Dewey, JR. (Holladay, USA)

    Objective: To determine the effects of the nanocatalytic drug, CNM-Au8, on brain energy metabolites in Parkinson’s Disease. Background: Converging lines of evidence are identifying brain…
  • MDS Virtual Congress 2021

    Benefits of Treatment with OnabotulinumtoxinA in Naive and Non-naive Patients with Cervical Dystonia are Sustained over Time: Preliminary Completer Analysis from CD PROBE

    P. Agarwal, M. Schwartz, A. Zuzek, A. Patel (Kirkland, USA)

    Objective: This analysis evaluated the sustained effects of onabotulinumtoxinA in patients with CD who were naive or non-naive to botulinum toxin at enrollment in CD…
  • MDS Virtual Congress 2021

    Pain in cervical dystonia: A meta-analysis of outcomes following treatment with abobotulinumtoxinA in randomized, controlled clinical studies

    R. Rosales, L. Cuffe, B. Regnault, R. Trosch (Manila, Philippines)

    Objective: The aim of this meta-analysis of pivotal studies was to evaluate the efficacy of abobotulinumtoxinA (AboBoNT-A) in reducing pain in patients with cervical dystonia…
  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 132
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley